Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Mind Medicine
(NASDAQ:MNMD)
Intraday
$8.56
-0.31
[-3.49%]
After-Hours
$8.56
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$8.56
-0.31
[-3.49%]
At close: Apr 24
$8.56
0
[0.00%]
After Hours: 7:59PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Mind Medicine Stock (NASDAQ:MNMD)
Mind Medicine Stock (NASDAQ: MNMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 19, 2024
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Caleb Naysmith
-
5 days ago
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
-
Apr 17, 2024, 9:13AM
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
-
Apr 17, 2024, 8:42AM
Monday, April 15, 2024
Leerink Partners Initiates Coverage On Mind Medicine with Outperform Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Apr 15, 2024, 10:30AM
Wednesday, April 10, 2024
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Apr 10, 2024, 10:56AM
Thursday, April 04, 2024
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Avi Kapoor
-
Apr 4, 2024, 5:18AM
Monday, April 01, 2024
MindMed Reports Voluntary Delisting From Cboe Canada; All Common Shares Will Remain Listed On Nasdaq
Benzinga Newsdesk
-
Apr 1, 2024, 5:28PM
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
-
Mar 29, 2024, 12:43PM
Wednesday, March 27, 2024
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Lara Goldstein
-
Mar 27, 2024, 10:25AM
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
-
Mar 20, 2024, 2:49PM
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
Benzinga Newsdesk
-
Mar 14, 2024, 12:42PM
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 14, 2024, 8:05AM
HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $75 Price Target
Benzinga Newsdesk
-
Mar 14, 2024, 7:18AM
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 13, 2024, 1:18PM
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Lara Goldstein
-
Mar 13, 2024, 11:33AM
Friday, March 08, 2024
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
Lara Goldstein
-
Mar 8, 2024, 1:01PM
RBC Capital Maintains Outperform on Mind Medicine, Raises Price Target to $22
Benzinga Newsdesk
-
Mar 8, 2024, 5:36AM
Thursday, March 07, 2024
S&P 500 Gains 1%; Kroger Earnings Top Views
Avi Kapoor
-
Mar 7, 2024, 2:31PM
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Mar 7, 2024, 1:35PM
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Lara Goldstein
-
Mar 7, 2024, 1:35PM
Roth MKM Maintains Buy on Mind Medicine, Raises Price Target to $36
Benzinga Newsdesk
-
Mar 7, 2024, 11:35AM
What's Going On With MindMed Stock Thursday?
Adam Eckert
-
Mar 7, 2024, 9:54AM
MindMed shares are trading higher after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120.
Benzinga Newsdesk
-
Mar 7, 2024, 9:52AM
Mind Medicine (MindMed) Priced Underwritten Offering of $175M Common Shares and Concurrent Private Placement at $6/Share
Benzinga Newsdesk
-
Mar 7, 2024, 7:17AM
Mind Medicine Says FDA Has Granted Breakthrough Designation To Its MM120 (Lysergide D-tartrate) Program For Treatment Of Generalized Anxiety Disorder
Benzinga Newsdesk
-
Mar 7, 2024, 6:02AM
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
-
Mar 4, 2024, 1:48PM
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $75 Price Target
Benzinga Newsdesk
-
Mar 1, 2024, 2:14PM
Thursday, February 29, 2024
RBC Capital Maintains Outperform on Mind Medicine, Raises Price Target to $15
Benzinga Newsdesk
-
Feb 29, 2024, 12:14PM
Wednesday, February 28, 2024
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Lara Goldstein
-
Feb 28, 2024, 2:52PM
MindMed 2023 EPS $(2.33), Cash Balance $99.7M As Of Dec. 31
Benzinga Newsdesk
-
Feb 28, 2024, 7:07AM
Earnings Scheduled For February 28, 2024
Benzinga Insights
-
Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Mind Medicine's Earnings Outlook
Benzinga Insights
-
Feb 27, 2024, 4:01PM
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
-
Feb 15, 2024, 10:55AM
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
-
Feb 15, 2024, 8:36AM
Monday, February 12, 2024
'FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says' - Marijuana Moment
Benzinga Newsdesk
-
Feb 12, 2024, 11:38AM
Monday, February 05, 2024
Elon Musk Says, 'If Drugs Helped My Productivity I'd Take Them' — This Psychedelic Bio-Tech Company Hopes To Help Build That Future
Caleb Naysmith
-
Feb 5, 2024, 12:04PM
Wednesday, January 31, 2024
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
Lara Goldstein
-
Jan 31, 2024, 7:05PM
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
-
Jan 27, 2024, 10:00AM
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
-
Jan 12, 2024, 4:55PM
Thursday, January 11, 2024
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
Lara Goldstein
-
Jan 11, 2024, 10:43AM
Mind Medicine Filed U.S. Patent Application #20240010628: Methods Of Manufacture Of R-MDMA
Charles Gross
-
Jan 11, 2024, 10:15AM
Monday, January 08, 2024
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
-
Jan 8, 2024, 2:33PM
'New Bipartisan Washington Bill Would Legalize Psilocybin Therapy For Veterans And First Responders' - Marijuana Moment
Benzinga Newsdesk
-
Jan 8, 2024, 1:55PM
MindMedMindMed Announces Business Updates And Anticipated Milestones For 2024
Benzinga Newsdesk
-
Jan 8, 2024, 7:50AM
Thursday, January 04, 2024
"DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination" - Marijuana Moment
Benzinga Newsdesk
-
Jan 4, 2024, 11:41AM
Monday, January 01, 2024
Psychedelic Stock Gainers And Losers From January 1, 2024
Benzinga Insights
-
Jan 1, 2024, 4:30PM
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
-
Dec 27, 2023, 10:09AM
Monday, December 18, 2023
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Lara Goldstein
-
Dec 18, 2023, 12:21PM
Thursday, December 14, 2023
Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
Lara Goldstein
-
Dec 14, 2023, 2:26PM
Mind Medicine Shares Resume Trade
Benzinga Newsdesk
-
Dec 14, 2023, 8:00AM
Show more